Similar articles

• Qualitative study of drug resistance in retroviral protease using structural modeling and site-directed mutagenesis.

  Culberson JC, Bush BL, Sardana VV. Culberson JC, et al. Methods Enzymol. 1994;241:385-94. doi: 10.1016/0076-6879(94)41075-5. Methods Enzymol. 1994. PMID: 7854190 Review. No abstract available.
• Crystallization and biochemical characterisation of simian immunodeficiency virus proteinase mutant.

  Corr BR, Wilderspin AF. Corr BR, et al. Biochem Soc Trans. 1994 Feb;22(1):55S. doi: 10.1042/bst022055s. Biochem Soc Trans. 1994. PMID: 8206284 No abstract available.
• Domain flexibility in retroviral proteases: structural implications for drug resistant mutations.

  Rose RB, Craik CS, Stroud RM. Rose RB, et al. Biochemistry. 1998 Feb 24;37(8):2607-21. doi: 10.1021/bi9716074. Biochemistry. 1998. PMID: 9485411
• Expression, characterisation and mutagenesis of the aspartic proteinase from equine infectious anaemia virus.

  Powell DJ, Bur D, Wlodawer A, Gustchina A, Payne SL, Dunn BM, Kay J. Powell DJ, et al. Eur J Biochem. 1996 Oct 15;241(2):664-74. doi: 10.1111/j.1432-1033.1996.00664.x. Eur J Biochem. 1996. PMID: 8917470
• Relationships of human immunodeficiency virus protease with eukaryotic aspartic proteases.

  Lin XL, Lin YZ, Tang J. Lin XL, et al. Methods Enzymol. 1994;241:195-224. doi: 10.1016/0076-6879(94)41066-6. Methods Enzymol. 1994. PMID: 7854179 Review. No abstract available.